Promoting and facilitating strategies to improve cardiovascular health worldwide

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



ISCP June 2019 newsletter available online

Posted on April 04, 2019

Latest newsletter including message from new ISCP President Augusto Gallino and more ISCP news and upcoming meetings. more

Walking intervention tied to long-term health benefits

Posted on June 25, 2019

Short-term walking interventions using pedometers resulted in fewer cardiovascular events and fractures after 4 years as well as sustained increases in physical... more

CREDENCE: Canagliflozin demonstrates CV, renal benefits in type 2 diabetes without CVD

Posted on June 25, 2019

SAN FRANCISCO — Among adults with type 2 diabetes and chronic kidney disease, the SGLT2 inhibitor canagliflozin reduced risk for a cardiovascular... more

AI with CTA may predict adverse events vs. other prediction scores

Posted on June 25, 2019

Coronary CTA assessed by machine learning was able to better distinguish patients who had an adverse event compared with the Coronary Artery... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  • Augusto Gallino


    Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX (more…) more

  • Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  • Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  • Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more